Company / Shares Outstanding
Crinetics Pharmaceuticals, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
95.6M
FY2025
5-year range
47.6M / 95.6M
FY2021-FY2025
Trend
+2.9%
vs FY2024
Sector context
#103 of 212
Health Care
What the data says
At 95575000.00, Crinetics Pharmaceuticals, Inc.'s shares outstanding ranks #110 of 212 in the Health Care sector. Shares Outstanding has increased for 6 consecutive years, from 24061.00 in FY2019 to 95575000.00 in FY2025.
Based on SEC 10-K filings.
95575000.00 in FY2025 with a 5-year CAGR of +31.5%.
Increased from 58071000.00 to 95575000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +21.1%
- 5-Year CAGR
- +31.5%
- 10-Year CAGR
- -
Sector benchmark
#110 of 212 in Health CareTop 51% of 212This company 95.6M Sector average 306.7M
▼
-68.8% below sector average
Key checks
Key Insights
- Crinetics Pharmaceuticals, Inc.'s shares outstanding has grown for 6 consecutive years.
- In FY2025, shares outstanding increased 2.9% year-over-year.
- Ranks #103 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 95.6M | +2.9% |
| FY2024 | 92.9M | +60.0% |
| FY2023 | 58.1M | +7.8% |
| FY2022 | 53.9M | +13.2% |
| FY2021 | 47.6M | +96.2% |
| FY2020 | 24.3M | +100739.5% |
| FY2019 | 24.1K | -98.4% |
| FY2018 | 1.5M | +13.0% |
| FY2017 | 1.4M | +35.6% |
| FY2016 | 1.0M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026